Tag: SaaS

Browse our exclusive articles!

10 Key Questions to Ask a VC, Antitrust and AI, and Investor Survey in Japan: TechCrunch+ Roundup

Seed-stage startups face a 52% decrease in deals for Q1 2023, urging founders to reassess the value of their investors. Law firms warn that AI-enabled technology development may create legal issues, and federal and state law violation risks. In contrast, the Fed's new initiative, FedNow, will allow instant payments 24/7/365, paving the way for fintech companies' growth, while Japan's VC market hit a record high in 2022. Learn more about these trends and the strategies of investors active in Japan's startup ecosystem in this informative article.

OpenAI’s Website Nearing One Billion Unique Monthly Users Following ChatGPT Launch

OpenAI's generative AI tool ChatGPT has driven a surge in website traffic, with over 847.8 million visitors in March, increasing 54% within a month.

OpenAI’s ChatGPT approaches monthly unique user record of 1 billion

OpenAI's website hits record-breaking numbers with 847.8 million unique visitors in March. The company's growth demonstrates the increasing importance of AI in businesses today.

AI Startup MindsDB Raises $25 Million to Make Machine Learning Accessible to All Developers

MindsDB, an AI startup, has raised $25m in seed funding to enhance its platform for developers, with over 100 data integrations, including OpenAI and Hugging Face. The CEO, Jorge Torres, said that the surge of interest in AI and machine learning has given MindsDB a boost.

Considerations for Pricing AI-Enabled SaaS

Learn about pricing considerations for SaaS companies integrating AI. The article emphasizes creating differentiated value and increased dollar retention. OpenAI is a third-party provider to enhance decision-making capabilities.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img